{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:28:06Z","timestamp":1791689286610,"version":"4.3.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>The aim of this survey was to examine the knowledge, attitudes, and behavior of gynecologists in terms of human papillomavirus (HPV) DNA testing as a primary screening tool for cervical cancer. A national cross-sectional web survey was carried out through multistage sampling using an overall sample of 1000 gynecologists. Gynecologists were asked to fill in a self-administered questionnaire exploring their knowledge, attitudes, and practice toward cervical cancer screening and HPV-DNA testing. A total of 582 gynecologists completed the web questionnaire. Of these, 24.5% were uncertain on the higher sensitivity of HPV-DNA compared with the Pap test, whereas 19% were uncertain on the role of the HPV-DNA test as a primary test in women younger than 30 years old and only 44.9% knew that a negative HPV-DNA test allows for an extension of the test interval to 5 years. Most gynecologists showed a definite positive attitude on the role of screening for cervical cancer prevention and were prepared to accept new technologies. The HPV-DNA test was considered highly effective by 86.9%, whereas 94% recommend\/perform HPV-DNA tests in women older than 30 years of age; 25.5% performed HPV-DNA as a primary test, followed by a Pap test in those cases that were positive. Only 56.3% recommended\/performed HPV-DNA tests 1 year after a positive HPV-DNA test, followed by a negative Pap test, whereas 42.9% recommended colposcopy. Although the use of the HPV-DNA test is very widespread among Italian gynecologists performing cervical cancer screening, there is lack of standardization of practices according to current guidelines.<\/jats:p>","DOI":"10.1097\/cej.0000000000000325","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T17:59:59Z","timestamp":1479923999000},"page":"249-256","source":"Crossref","is-referenced-by-count":10,"title":["Gynecologists and human papillomavirus DNA testing: exploring knowledge, attitudes, and practice in Italy"],"prefix":"10.1097","volume":"26","author":[{"given":"Claudia","family":"Caglioti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pileggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo G.A.","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"c1804","DOI":"10.1136\/bmj.c1804","article-title":"Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme","volume":"340","author":"Anttila","year":"2010","journal-title":"BMJ"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1089\/jwh.2010.2530","article-title":"Cancer screening practices among physicians in the national breast and cervical cancer early detection program","volume":"20","author":"Benard","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ypmed.2015.06.007","article-title":"Perceived effectiveness of HPV test as a primary screening modality among US providers","volume":"78","author":"Cooper","year":"2015","journal-title":"Prev Med"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12874-015-0016-z","article-title":"Exploring physician specialist response rates to web-based surveys","volume":"15","author":"Cunningham","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.5858\/arpa.2013-0620-OA","article-title":"An assessment of gynecological cytology screening practices among health care providers nationwide","volume":"139","author":"Darwish-Yassine","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amepre.2003.12.013","article-title":"Physician response rates to a mail survey by specialty and timing of incentive","volume":"26","author":"Delnevo","year":"2004","journal-title":"Am J Prev Med"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/oxfordjournals.aje.a117485","article-title":"Meta-analysis of Pap test accuracy","volume":"14","author":"Fahey","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R12-20231002","first-page":"1424","article-title":"Effects of various methodologic strategies: survey response rates among Canadian physicians and physicians-in-training","volume":"54","author":"Grava-Gubins","year":"2008","journal-title":"Can Fam Physician"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11606-015-3449-5","article-title":"Provider attitudes and screening practices following changes in breast and cervical cancer screening guidelines","volume":"31","author":"Haas","year":"2016","journal-title":"J Gen Intern Med"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/0163278712474001","article-title":"Health care provider surveys in the United Sates, 2000\u20132010: a review","volume":"36","author":"McLeod","year":"2013","journal-title":"Eval Health Prof"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ijc.28640","article-title":"Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials","volume":"135","author":"Pileggi","year":"2014","journal-title":"Int J Cancer"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2288-14-76","article-title":"The effectiveness of recruitment strategies on general practitioner\u2019s survey response rates \u2013 a systematic review","volume":"14","author":"Pit","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s11606-010-1415-9","article-title":"Association between physician speciality and uptake of new medical technologies: HPV tests in Florida Medicaid","volume":"25","author":"Price","year":"2010","journal-title":"J Gen Intern Med"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"447.e1","DOI":"10.1016\/j.ajog.2011.06.001","article-title":"Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States","volume":"205","author":"Roland","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ypmed.2013.04.012","article-title":"Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Center","volume":"57","author":"Roland","year":"2013","journal-title":"Prev Med"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R28-20231002","first-page":"1","article-title":"HTA report HPV DNA based primary screening for cervical cancer precursors","volume":"36","author":"Ronco","year":"2012","journal-title":"Epidemiol Prev"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/canjclin.56.1.11","article-title":"American Cancer Society Guidelines for the early detection of cancer","volume":"56","author":"Smith","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.ajog.2014.06.057","article-title":"Adherence to the 2012 national cervical cancer screening guidelines: a pilot study","volume":"212","author":"Teoh","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0163278707307899","article-title":"Methodologies for improving response rates in surveys of physicians","volume":"30","author":"VanGeest","year":"2007","journal-title":"Eval Health Prof"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/LGT.0000000000000008","article-title":"Adherence to cervical cancer screening guidelines by gynecologists in the Pacific Northwest","volume":"18","author":"Verrilli","year":"2014","journal-title":"J Low Genit Tract Dis"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1756-0500-5-129","article-title":"Does an offer for a free on-line continuing medical education (CME) activity increase physician survey response rate? A randomized trial","volume":"5","author":"Viera","year":"2012","journal-title":"BMC Res Notes"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201705000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:05:21Z","timestamp":1696273521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201705000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000325","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}